Atomera Provides First Quarter 2023 Results

Rhea-AI Summary

Atomera Incorporated (NASDAQ:ATOM) provided a corporate update and financial results for Q1 2023, reporting a net loss of
$5.0 million ($0.21 per share), compared to a loss of $4.1 million ($0.18 per share) in Q1 2022. Notable highlights included a definitive commercial license agreement with STMicroelectronics and ongoing development in the higher voltage power market. The company had $17.1 million in cash and equivalents as of March 31, 2023, down from $21.2 million at the end of 2022. Management emphasized their focus on converting existing engagements into further licensing agreements while navigating the risks tied to early-stage operations, including reliance on undetermined revenue streams and potential setbacks in technology implementation.

Positive

• Definitive commercial license executed with STMicroelectronics.
• Development of promising technology for the higher voltage power market.

Negative

• Net loss increased to $5.0 million in Q1 2023 from $4.1 million in Q1 2022.
• Cash decreased from $21.2 million at the end of 2022 to $17.1 million by March 31, 2023.
• Risks associated with reliance on undetermined revenue streams and early-stage operations.

LOS GATOS, CA / ACCESSWIRE / April 26, 2023 /­­ Atomera Incorporated (NASDAQ:ATOM), a semiconductor materials and technology licensing company, today provided a corporate update and announced financial results for the first quarter ended March 31, 2023.

Recent Company Highlights

• Executed definitive commercial license with STMicroelectronics
• Developing promising new technology for the higher voltage power market
• Joined American Semiconductor Innovation Coalition (ASIC)

Management Commentary

"The new commercial license agreement demonstrates Atomera is moving toward production, and we believe MST will become increasingly utilized among leading semiconductor manufacturers," said Scott Bibaud, President and CEO. "The industry's current period of investment in new technology is benefitting us as we showcase MST's improvements over standard silicon to the customers in our pipeline. Our focus is to convert existing engagements to more license agreements."

Financial Results

The Company incurred a net loss of ($5.0) million, or ($0.21) per basic and diluted share in the first quarter of 2023, compared to a net loss of ($4.1) million, or ($0.18) per basic and diluted share, for the first quarter of 2022. Adjusted EBITDA (a non-GAAP financial measure) in the first quarter of 2023 was a loss of ($4.2) million compared to an adjusted EBITDA loss of ($3.3) million in the first quarter of 2022.

The Company had $17.1 million in cash, cash equivalents and short-term investments as of March 31, 2023, compared to $21.2 million as of December 31, 2022.

The total number of shares outstanding was 24.3 million as of March 31, 2023.

First Quarter 2023 Results Webinar

Atomera will host a live video webinar today to discuss its financial results and recent progress.
Date: Wednesday, April 26, 2023
Time: 2:00 p.m. PT (5:00 p.m. ET)
Webcast: Accessible at https://ir.atomera.com

Note about Non­-GAAP Financial Measures

In addition to the unaudited results presented in accordance with generally accepted accounting principles, or GAAP, in this press release, Atomera presents adjusted EBITDA, which is a non­-GAAP financial measure. Adjusted EBITDA is determined by taking net loss and eliminating the impacts of interest, depreciation, amortization and stock-­based compensation. Our definition of adjusted EBITDA may not be comparable to the definitions of similarly-­titled measures used by other companies. We believe that this non­-GAAP financial measure, viewed in addition to and not in lieu of our reported GAAP results, provides useful information to investors by providing a more focused measure of operating results. This metric is used as part of the Company's internal reporting to evaluate its operations and the performance of senior management. A table reconciling this measure to the comparable GAAP measure is available in the accompanying financial tables below.

About Atomera Incorporated

Atomera Incorporated is a semiconductor materials and technology licensing company focused on deploying its proprietary, silicon-proven technology into the semiconductor industry. Atomera has developed Mears Silicon Technology™ (MST^®), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies already in the semiconductor industry roadmap. More information can be found at www.atomera.com

Safe Harbor

This press release contains forward-­looking statements concerning Atomera Incorporated, including statements regarding the prospects for the semiconductor industry generally and the ability of our MST technology to significantly improve semiconductor performance. Those forward­-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially. Among those factors are: (1) the fact that, to date, we have only recognized minimal engineering services and licensing revenues and we have not yet commenced principal revenue producing operations, thus subjecting us to all of the risks inherent in an early-stage enterprise; (2) the risk that STMicroelectronics does not proceed with MST in its manufacturing process or does not take MST-enabled products to market, (3) risks related to our ability to successfully complete the milestones in our joint development agreements or, even if successfully completed, to reach a commercial distribution license with our JDA customers; (4) risks related to our ability to advance licensing arrangements with our integration licensees to royalty-based manufacturing and distribution licenses or our ability to add other licensees; (5) risks related to our ability to raise sufficient capital, as and when needed, to pursue the further development, licensing and commercialization of our MST technology; (6) our ability to protect our proprietary technology, trade secrets and know­-how and (7) those other risks disclosed in the section "Risk Factors" included in our Annual Report on Form 10-K filed with the SEC on February 15, 2023. We caution readers not to place undue reliance on any forward-­looking statements. We do not undertake, and specifically disclaim any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.

-- Financial Tables Follow -

Atomera Incorporated
Condensed Balance Sheets
(in thousands, except per share data)

	March 31,				December 31,
	2023				2022
	(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	12,118			$	21,184
Short-term investments		4,934				-
Prepaid expenses and other current assets		303				418
Total current assets		17,355				21,602
Property and equipment, net		153				158
Long-term prepaid maintenance and supplies		91				91
Security deposit		14				14
Operating lease right-of-use asset		648				700
Financing lease right-of-use-asset		3,874				4,164
Total assets	$	22,135			$	26,729
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable	$	423			$	397
Accrued expenses		242				173
Accrued payroll related expenses		292				967
Current operating lease liability		247				245
Current financing lease liability		1,240				1,126
Total current liabilities		2,444				2,908
Long-term operating lease liability		475				521
Long-term financing lease liability		2,683				2,986
Total liabilities		5,602				6,415
Commitments and contingencies		-				-
Stockholders' equity:
Preferred stock $0.001 par value, authorized 2,500 shares; none issued and outstanding at March 31, 2023 and December 31, 2022		-				-
Common stock: $0.001 par value, authorized 47,500 shares; 24,330 and 23,973 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively		24				24
Additional paid-in capital		204,825				203,585
Other comprehensive income (loss)		(2)				-
Accumulated deficit		(188,314)				(183,295)
Total stockholders' equity		16,533				20,314
Total liabilities and stockholders' equity	$	22,135			$	26,729

Atomera Incorporated
Condensed Statements of Operations
(in thousands, except per share data)

	Three Months Ended
	March 31,				December 31,				March 31,
	2023				2022				2022
	(Unaudited)				(Unaudited)				(Unaudited)
Revenue	$	-				5			$	375
Cost of revenue		-				-				81
Gross margin		-				5				294
Operating expenses
Research and development		3,036				2,523				2,339
General and administrative		1,742				1,559				1,648
Selling and marketing		389				329				325
Total operating expenses		5,167				4,411				4,312
Loss from operations		(5,167)				(4,406)				(4,018)
Other income (expense)
Interest income		199				189				3
Interest expense		(53)				(55)				(71)
Other income (expense), net		2				-				-
Total other income (expense), net		148				134				(68
Net loss	$	(5,019)			$	(4,272)			$	(4,086)
Net loss per common share, basic	$	(0.21)			$	(0.18)			$	(0.18)
Net loss per common share, diluted	$	(0.21)			$	(0.18)			$	(0.18)
Weighted average number of common shares outstanding, basic		23,660				23,538				22,853
Weighted average number of common shares outstanding, diluted		23,660				23,538				22,853

Atomera Incorporated
Reconciliation to Non-GAAP EBITDA
(Unaudited)

	Three Months Ended
	March 31,				December 31,				March 31,
	2023				2022				2022
Net loss (GAAP)	$	(5,019)			$	(4,272)			$	(4,086)
Depreciation and amortization		20				19				20
Stock-based compensation		927				893				726
Interest income		(199)				(189)				(3)
Interest expense		53				55				71
Net loss non-GAAP EBITDA	$	(4,218)			$	(3,494)			$	(3,272)

Investor Contact:

Bishop IR
Mike Bishop
(415) 894-9633
investor@atomera.com

SOURCE: Atomera, Inc

View source version on accesswire.com:
https://www.accesswire.com/751412/Atomera-Provides-First-Quarter-2023-Results

FAQ

What were Atomera's financial results for Q1 2023?

Atomera reported a net loss of $5.0 million or $0.21 per share for Q1 2023, compared to a $4.1 million loss or $0.18 per share in Q1 2022.

What is the significance of the commercial license with STMicroelectronics for ATOM?

The commercial license indicates progress towards production for Atomera's technology, which may enhance its market adoption among semiconductor manufacturers.

How much cash did Atomera have as of March 31, 2023?

As of March 31, 2023, Atomera had $17.1 million in cash and equivalents, down from $21.2 million at the end of 2022.

What challenges does Atomera face in its business operations?

Atomera faces risks associated with being an early-stage enterprise, including reliance on yet-to-be-determined revenue and potential setbacks in technology implementation.